Pharmanutra S.p.A., a nutraceutical company, engages in the research and development and marketing of food supplements and medical devices in Europe, the Middle East, Far East, North America, South America, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It offers Sucrosomial, a delivery system that optimises nutrient transport and absorption for minimising gastrointestinal side effects; and Cetylated Fatty Acids, a formulation for muscle and joint recovery in physiotherapy and sports. The company also sells instrumentation and software for body bioimpedance analysis through agents, distributors, and online sales. Pharmanutra S.p.A. was founded in 2000 and is headquartered in Pisa, Italy.
Metrics to compare | PHNU | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPHNUPeersSector | |
|---|---|---|---|---|
P/E Ratio | 37.9x | 18.0x | 12.3x | |
PEG Ratio | 1.84 | 0.00 | 0.03 | |
Price/Book | 10.6x | 2.4x | 1.5x | |
Price / LTM Sales | 5.7x | 1.4x | 0.9x | |
Upside (Analyst Target) | 7.3% | 11.9% | 22.3% | |
Fair Value Upside | Unlock | 16.2% | 11.1% | Unlock |